A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Dragonfly Therapeutics
AstraZeneca
Conjupro Biotherapeutics, Inc.
UNC Lineberger Comprehensive Cancer Center
IRCCS Azienda Ospedaliero-Universitaria di Bologna
AbbVie
Eisai Inc.
Eli Lilly and Company
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
AbbVie
NeoImmuneTech
Revolution Medicines, Inc.
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Daiichi Sankyo
UMC Utrecht
Hoffmann-La Roche
AstraZeneca
Pfizer
University of Aarhus
Nuvectis Pharma, Inc.
Palo Alto Veterans Institute for Research
ViroMissile, Inc.
Replimune Inc.
Amgen
Hospices Civils de Lyon
Cancer Research UK
Sichuan Enray Pharmaceutical Sciences Company
Pfizer
Astellas Pharma Inc
Hoffmann-La Roche
Duke University
AstraZeneca
A2 Biotherapeutics Inc.
University of Florida
VA Office of Research and Development
Amgen
Pfizer
VA Office of Research and Development
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
National Institutes of Health Clinical Center (CC)
A2 Biotherapeutics Inc.
Tempus AI
Werewolf Therapeutics, Inc.
Royal North Shore Hospital